עקוב אחר
Megan B. Murray
Megan B. Murray
Harvard Medical School
כתובת אימייל מאומתת בדומיין hms.harvard.edu
כותרת
צוטט על ידי
צוטט על ידי
שנה
Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies
CY Jeon, MB Murray
PLoS medicine 5 (7), e152, 2008
20132008
Transmission dynamics and control of severe acute respiratory syndrome
M Lipsitch, T Cohen, B Cooper, JM Robins, S Ma, L James, ...
science 300 (5627), 1966-1970, 2003
18492003
The impact of diabetes on tuberculosis treatment outcomes: a systematic review
MA Baker, AD Harries, CY Jeon, JE Hart, A Kapur, K Lönnroth, ...
BMC medicine 9, 1-15, 2011
10052011
Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis
HH Lin, M Ezzati, M Murray
PLoS medicine 4 (1), e20, 2007
9832007
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ...
The lancet Respiratory medicine 5 (4), 291-360, 2017
6962017
Tuberculosis drug resistance mutation database
A Sandgren, M Strong, P Muthukrishnan, BK Weiner, GM Church, ...
PLoS medicine 6 (2), e1000002, 2009
6592009
The adverse effect of iron repletion on the course of certain infections.
MJ Murray, AB Murray, MB Murray, CJ Murray
Br Med J 2 (6145), 1113-1115, 1978
5711978
The adverse effect of iron repletion on the course of certain infections.
CJM MJ Murray, AB Murray, MB Murray
British Medical Journal 2, 1113-1115, 1978
5711978
Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis
MH Hazbón, M Brimacombe, M Bobadilla del Valle, M Cavatore, ...
Antimicrobial agents and chemotherapy 50 (8), 2640-2649, 2006
5492006
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
CB Ford, RR Shah, MK Maeda, S Gagneux, MB Murray, T Cohen, ...
Nature genetics 45 (7), 784-790, 2013
5142013
Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis
MR Farhat, BJ Shapiro, KJ Kieser, R Sultana, KR Jacobson, TC Victor, ...
Nature genetics 45 (10), 1183-1189, 2013
5042013
Interpreting Expression Data with Metabolic Flux Models: Predicting Mycobacterium tuberculosis Mycolic Acid Production
C Colijn, A Brandes, J Zucker, DS Lun, B Weiner, MR Farhat, TY Cheng, ...
PLoS computational biology 5 (8), e1000489, 2009
4622009
Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness
T Cohen, M Murray
Nature medicine 10 (10), 1117-1121, 2004
3962004
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
K Dheda, T Gumbo, NR Gandhi, M Murray, G Theron, Z Udwadia, ...
The lancet Respiratory medicine 2 (4), 321-338, 2014
3552014
Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis
KR Jacobson, DB Tierney, CY Jeon, CD Mitnick, MB Murray
Clinical infectious diseases 51 (1), 6-14, 2010
3492010
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ...
European Respiratory Journal 50 (6), 2017
3452017
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
HH Lin, M Murray, T Cohen, C Colijn, M Ezzati
The Lancet 372 (9648), 1473-1483, 2008
3432008
Genotypic Analysis of Mycobacterium tuberculosis in Two Distinct Populations Using Molecular Beacons: Implications for Rapid Susceptibility Testing
AS Piatek, A Telenti, MR Murray, H El-Hajj, WR Jacobs Jr, FR Kramer, ...
Antimicrobial agents and chemotherapy 44 (1), 103-110, 2000
3382000
Tuberculosis and poverty: why are the poor at greater risk in India?
O Oxlade, M Murray
PloS one 7 (11), e47533, 2012
3222012
Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing
CRyPTIC Consortium and the 100,000 Genomes Project
New England Journal of Medicine 379 (15), 1403-1415, 2018
3212018
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20